CACLP 2025 Unites Global Innovators in IVD Industry
|
By LabMedica International staff writers Posted on 11 Mar 2025 |
|
CACLP (Shanghai, China) will be holding the 22nd China International In Vitro Diagnostic Expo, the largest and most influential gathering of the IVD industry in China, 22-24 March 2025 at the Hangzhou Grand Convention & Exhibition Center. CACLP 2025 promises to be a world-class showcase of the latest innovations, professional networking and business opportunities.
Over 1,300 exhibitors will present their cutting-edge technologies across seven major categories spanning Halls 2 to 8, with more than 60 companies launching their new products onsite. CACLP 2025 will also feature dedicated Canada and Germany Pavilions, highlighting the leading diagnostic companies and innovations from North America and Europe. Government entities, medical associations, and industry organizations from countries including Canada, Germany, India, South Korea, Switzerland, the U.K., the U.S., Vietnam and beyond will actively participate, contributing to onsite discussions, especially dozens of regulatory and product innovations roadshows in the Presentation Area of Halls 5 and 7. With professional visitors and international buyers recruited from key markets worldwide, CACLP 2025 will serve as a premier platform for global networking and cross-border collaboration.
As a hub for AI and technology advancements, Hangzhou provides the perfect backdrop for CACLP 2025, which will introduce the 1st AI and Digital Twin Technology Academic Salon, exploring the transformative role of AI in diagnostics. Additionally, onsite activities will spotlight many key industry trends, including veterinary diagnostics, global investment, and primary healthcare. The event will debut three groundbreaking forums addressing critical industry shifts. The 1st Human-to-Animal Medical Device Transition Forum, co-hosted with the East and West Small Animal Veterinary Conference, will examine how human diagnostic innovations are shaping the veterinary healthcare market, with a focus on standardization, regulations, and commercialization. The 1st National Primary Healthcare Laboratory Forum addresses quality control, test result standardization, and access to advanced diagnostics, supporting the growth of grassroots laboratory services. The 1st China IVD Companies Globalization Forum will feature insights from government officials, regulatory experts, and industry leaders, providing strategic guidance on global market trends, regulatory pathways, and international expansion.
In addition to the exhibition and newly launched activities, CACLP remains a hub for academic and industry dialogues. Further high-level conferences and forums will be primarily held in Hall 1 – the Convention Center. The 10th China Experimental Medicine Conference (CEMC), themed "A Decade Together for a Shared Future", will bring together leading academicians, hospital presidents, and experts in experimental medicine and biomedical engineering. Discussions will cover early disease screening, personalized treatment, AI integration, and other cutting-edge advancements. The conference will also feature sessions dedicated to pathology, molecular diagnostics, coagulation, mass spectrometry, and more specific topics. The 12th China IVD Industry Development Conference (CIIDC), under the theme "Empowering the Future with New Intelligence", will explore the future of the IVD industry through discussions on sustainability, international expansion, healthcare reforms, technological advancements, investment strategies, and industry development.
A key highlight will be the official release of the Annual Report of China IVD Industry 2024, providing essential insights into market performance and trends. Additional forums including Enlightening Lab Med – The 8th IVD Youth Entrepreneur Forum (ELMY), the 7th China IVD Distribution Enterprise Forum (CIDEF), and the 5th China Key Raw Material & Parts Forum (CKRMPF), will offer targeted discussions for different segments of the IVD industry. With two main tradeshows and over 100 concurrent activities, and unmatched networking opportunities, CACLP 2025 is the go-to event for professionals in diagnostics, laboratory medicine, and healthcare.
Related Links:
CACLP
Latest Industry News
- Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
- Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
- New Collaboration to Advance Microbial Identification for Infectious Disease Diagnostics
- Tecan Acquires ELISA Immunoassay Assets from Revvity's Cisbio Bioassays
- Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration
- Philips and Ibex Expand Partnership to Enhance AI-Enabled Pathology Workflows
- Grifols and Inpeco Partner to Deliver Transfusion Medicine ‘Lab of The Future’
- Research Collaboration to Advance AI-Enhanced, Real-Time Optical Imaging in Lung Cancer Biopsy
- Bio-Rad to Acquire Digital PCR Developer Stilla Technologies
- ABL Signs Know-How License and Transfer Agreement for Siemens’ Fast Track Diagnostics PCR Portfolio
- Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
- New Partnership Revolutionizes Analyses of Biological Samples
- Medlab Middle East Looks to The Future of Laboratories
- Medix Biochemica Acquires German Immunoassay Solutions Developer Candor Bioscience
- bioMérieux Acquires Norwegian Immunoassay Start-Up SpinChip Diagnostics
- Danaher Partners with Healthcare AI Company Innovaccer on Novel Digital and Diagnostic Solutions
Channels
Clinical Chemistry
view channel
Mass Spectrometry Detects Bacteria Without Time-Consuming Isolation and Multiplication
Speed and accuracy are essential when diagnosing diseases. Traditionally, diagnosing bacterial infections involves the labor-intensive process of isolating pathogens and cultivating bacterial cultures,... Read more
First Comprehensive Syphilis Test to Definitively Diagnose Active Infection In 10 Minutes
In the United States, syphilis cases have surged by nearly 80% from 2018 to 2023, with 209,253 cases recorded in the most recent year of data. Syphilis, which can be transmitted sexually or from mother... Read more
Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse
Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more
Molecular Diagnostics
view channel
First-in-Class Diagnostic Blood Test Detects Axial Spondyloarthritis
Axial spondyloarthritis (axSpA) is a chronic inflammatory autoimmune condition that typically affects individuals during their most productive years, with symptoms often emerging before the age of 45.... Read more
New Molecular Label to Help Develop Simpler and Faster Tuberculosis Tests
Tuberculosis (TB), the deadliest infectious disease globally, is responsible for infecting an estimated 10 million people each year and causing over 1 million deaths annually. While chest X-rays and molecular... Read more
Biomarker Discovery Paves Way for Blood Tests to Detect and Treat Osteoarthritis
The number of individuals affected by osteoarthritis is projected to exceed 1 billion by 2050. The primary risk factor for this common, often painful chronic joint condition is aging, and, like aging itself,... Read more
Hematology
view channel
First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes
Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read more
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Immunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read more
Microbiology
view channel
Molecular Stool Test Shows Potential for Diagnosing TB in Adults with HIV
Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis, led to 1.25 million deaths in 2023, with 13% of those occurring in people living with HIV. The current primary diagnostic method for... Read more
New Test Diagnoses Bacterial Meningitis Quickly and Accurately
Bacterial meningitis is a potentially fatal condition, with one in six patients dying and half of the survivors experiencing lasting symptoms. Therefore, rapid diagnosis and treatment are critical.... Read more
Pathology
view channel
Groundbreaking Chest Pain Triage Algorithm to Transform Cardiac Care
Cardiovascular disease is responsible for a third of all deaths worldwide, and chest pain is the second most common reason for emergency department (ED) visits. With EDs often being some of the busiest... Read more
AI-Based Liquid Biopsy Approach to Revolutionize Brain Cancer Detection
Detecting brain cancers remains extremely challenging, with many patients only receiving a diagnosis at later stages after symptoms like headaches, seizures, or cognitive issues appear. Late-stage diagnoses... Read more
Technology
view channel
Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer
Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses
Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more